New patent for Ocuphire drug RYZUMVI

Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…


New patent for Axsome Malta drug SUNOSI

Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from two suppliers. There are twenty-three patents…
The post New patent for Axsome Malta drug SUNOSI appeared first on DrugP…


Biotechblog